HBK Sorce咨询公司将其在波士顿科学公司的股份减少了12.6%,达到9 106股。 HBK Sorce Advisory LLC reduced its stake in Boston Scientific Co. by 12.6% to 9,106 shares.

HBK Sorce咨询公司将其在波士顿科学公司(BSX)的股份减少了12.6%,目前持有9 106股,价值701 000美元。 HBK Sorce Advisory LLC reduced its stake in Boston Scientific Co. (BSX) by 12.6%, now holding 9,106 shares valued at $701,000. 机构投资者拥有公司89.07%的股份。 Institutional investors own 89.07% of the company. 分析师最近的评级显示, 平均目标价格为85.38美元, Recent analyst ratings indicate a consensus "Moderate Buy" with an average price target of $85.38. 波士顿科学社报告,Q2收入为每股0.62美元,收入为41.2亿美元,比上一年增加14.5%。 Boston Scientific reported Q2 earnings of $0.62 per share and revenue of $4.12 billion, reflecting a 14.5% increase year-over-year. 注意到内部交易与EVP Wendy Carruthers出售股票的交易。 Insider trading was noted with EVP Wendy Carruthers selling shares.